LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Hosted on MSN
Cochlear targets 50,000 implant recipients in FY 2025 with new product launches and cloud investments
CEO Dig Howitt highlighted a 6% increase in net sales on a constant currency basis, driven by 13% growth in Cochlear implant revenue and 22% growth in Acoustics revenue. Services revenue declined by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback